AMPK, the metabolic syndrome and cancer
Top Cited Papers
- 1 February 2005
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 26 (2) , 69-76
- https://doi.org/10.1016/j.tips.2004.12.011
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Post-translational modification of p53 in tumorigenesisNature Reviews Cancer, 2004
- AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanismsPublished by Elsevier ,2004
- AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exerciseBiochemical and Biophysical Research Communications, 2004
- Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor geneOncogene, 2004
- Chronic activation of AMP-activated kinase as a strategy for slowing agingMedical Hypotheses, 2004
- Dysregulation of cellular signaling by HER2 in breast cancerSeminars in Oncology, 2003
- Increased AMP:ATP Ratio and AMP-activated Protein Kinase Activity during Cellular Senescence Linked to Reduced HuR FunctionJournal of Biological Chemistry, 2003
- Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formationOncogene, 2002
- Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinaseNature, 2002
- Cell Cycle Regulation via p53 Phosphorylation by a 5′-AMP Activated Protein Kinase Activator, 5-Aminoimidazole- 4-Carboxamide-1-β- -Ribofuranoside, in a Human Hepatocellular Carcinoma Cell LineBiochemical and Biophysical Research Communications, 2001